Brazil, March 25 -- Biofy Technologies, a tech company tackling the growing challenges of antibiotic resistance, is leveraging Oracle Cloud Infrastructure (OCI) to help it identify bacterial infections and determine resistance profiles. With its industry-leading generative AI capabilities and full-suite of managed open-source cloud services, OCI has helped Biofy reduce the time to diagnose antibiotic resistance from five days to less than four hours and gained 50 percent better performance at up to half the cost of other cloud providers.New antibiotic resistance mechanisms are spreading globally and threatening the ability to treat common infectious diseases. DNA sequencing is the most common and accurate method to identify the specific bac...